Star Health and Allied Insurance Co Ltd (BOM:543412)
₹ 480.6 -8.55 (-1.75%) Market Cap: 282.39 Bil Enterprise Value: 284.14 Bil PE Ratio: 33.76 PB Ratio: 4.10 GF Score: 57/100

Q2 2025 Star Health and Allied Insurance Company Ltd Earnings Call Transcript

Oct 30, 2024 / 03:00AM GMT
Release Date Price: ₹515.5 (-3.78%)

Key Points

Positve
  • Star Health and Allied Insurance Co Ltd (BOM:543412) reported a 17% growth in Gross Written Premium (GWP), outperforming the overall industry growth.
  • The company's agency vertical contributed significantly, with a 23% growth in fresh business for Q2 FY25 compared to the previous year.
  • Digital business showed robust growth, contributing 7.4% to the overall business with a 41% increase in fresh business.
  • Investment income for H1 FY25 grew to INR650 crores, up from INR505 crores in H1 FY24.
  • The solvency ratio stood at 2.24x, well above the regulatory requirement of 1.5x, indicating strong financial health.
Negative
  • The combined ratio for H1 FY25 increased to 101.1% from 98.4% in H1 FY24, indicating higher operational costs relative to income.
  • The claims ratio rose to 70.2% in H1 FY25 from 67.1% in H1 FY24, driven by increased medical claims severity and frequency.
  • Profit after tax (PAT) for Q2 FY25 decreased to INR111 crores from INR125 crores in Q2 FY24.
  • The company experienced a cyber attack, raising concerns about data security and operational risks.
  • There is a noted increase in loss ratios due to higher medical inflation and changes in consumer behavior post-COVID, impacting profitability.
Operator

Ladies and gentlemen, good day, and welcome to Star Health and Allied Insurance Company Limited Q2 and H1 FY 2025 earnings conference call. (Operator Instructions)

I now hand the conference over to Mr. Pratik Patil from Adfactors PR Investor Relations team. Thank you, and over to you, sir.

Pratik Patil
Adfactors PR - Analyst

Thank you, Steve. Good morning, everyone. From the senior management we have with us: Mr. Anand Roy, Managing Director and Chief Executive Officer; Mr. Nilesh Kambli, Chief Financial Officer; Mr. Aneesh Srivastava, Chief Investment Officer; Mr. Amitabh Jain, Chief Operating Officer; and Mr. Aditya Biyani, Chief Strategy and Investor Relations Officer.

Before we begin this conference call, I would like to mention that some of the statements made during the course of today's call may be forward-looking in nature, including those related to the future financial and operating performances, benefits and synergies of the company's strategies, future opportunities and growth of the market of the company's services. Further, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot